Copyright
©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1798-1813
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1798
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1798
Figure 1 Hypoxia aggravated acute liver failure and increased the expression of hypoxia inducible factor-1α and its acetylation.
A: The representative images of hematoxylin and eosin staining of liver in each group; B: Western blotting was performed to measure the levels of Sirtuin1 (Sirt1), Bcl-2 adenovirus E1B-interacting protein 3 (Bnip3) and carbonic anhydrase 9 (CA9) in liver tissues; C: The representative images of immunofluorescence staining for Acetyl-lysine and hypoxia inducible factor (HIF)-1α. Data shown are means ± standard deviation of three separate experiments. aP < 0.05 vs Control group; bP < 0.05 vs Lipopolysaccharide (LPS)-treated group; one-way analysis of variance combined with Bonferroni's post hoc test; the error bars indicate the standard deviations. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Cao P, Chen Q, Shi CX, Wang LW, Gong ZJ. Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α. World J Gastroenterol 2022; 28(17): 1798-1813
- URL: https://www.wjgnet.com/1007-9327/full/v28/i17/1798.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i17.1798